Secondly, bioinformatical approaches should be used to recognize the presence of the antigens in all cancer cells, and finally, targeting different neoantigens could minimize the tumor heterogeneity and also the chances of tumor resistance, due to the antigen loss or loss of specific MHC molecules [58]. The gene discussed is HLA-C; the disease is neoplasm.